A clinical trial of the effect of the elemental diet (Elental) on adverse events of DCF therapy (Docetaxel plus 5-fluorouracil and cisplatin) in patients with esophageal cancer.
Phase 3
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000007609
- Lead Sponsor
- Department of Gastroenterology Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients (1) patients considered inadequate for inclusion in this trial by the physician (2) patients with the past history of hypersensitivity to Elental
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method